Bristol Myers inks $11B BioNTech deal to join bispecific gold rush, leaping ahead of Merck and Pfizer

fiercebiotech.com/biotech/bristol-myers-inks-11b-biontech-deal-join-bispecific-gold-rush-leaping-ahead-merck-and

This story appeared on fiercebiotech.com, 2025-06-02 17:03:52.974000.
The Entire Business World on a Single Page. Free to Use →